Statement of Cash Flows - USD ($)	6 Months Ended
	Jun. 30, 2016	Jun. 30, 2015
Cash Flows From Operating Activities:
Net income (loss)	$ (935,510)	$ (5,784,557)
Adjustments to reconcile net income to net cash provided by (used for) operating activities
Depreciation	0	6,327
Stock-based compensation expense	728,125	4,075,536
Write off of deposit paid toward Specialty Pharma acquisition	0	50,000
Changes in operating Assets & Liabilities
Cash overdraft	4,279	0
(Increase)/decrease in prepaid expenses	1,938	(17,315)
Increase/(Decrease) in accounts payable and accrued expenses	78,789	199,500
Increase/(Decrease) in accrued payable - related party	100,000	0
Net cash provided by (used for) operating activities	(22,379)	(1,470,509)
Cash Flows From Investing Activities:
Purchase of fixed assets	0	(2,078)
Net cash provided by (used for) investing activities	0	(2,078)
Cash Flows From Financing Activities:
Proceeds from (paydown of) related party loans	19,758	0
Cash acquired in acquisition of Canna Colorado	0	1,245
Proceeds from sales of common stock	0	804,500
Net cash provided by (used for) financing activities	19,758	805,745
Net Increase (Decrease) In Cash and Cash Equivalents	(2,621)	0
Cash and Cash Equivalents At The Beginning Of The Period	2,621	1,605,239
Cash and Cash Equivalents At The End Of The Period	0	1,597,500
Schedule of Non-Cash Investing and Financing Activities
Value of stock issued in litigation settlement	0	1,597,500
Supplemental Disclosure
Cash paid for interest	423	1,553
Cash paid for income taxes	$ 0	$ 500